Accordingly, aberrant expression of ZEB2 in melanoma cells may promote terminal differentiation and decreased tumorigenic capacity upon xenograft in nude mice, while intermediate levels of ZEB2 in transgenic mice would be compatible with proliferation. This evidence concerns the gene ZEB2 and melanoma.